BioGeneration Ventures

BioGeneration Ventures (BGV) is an early-stage venture capital firm based in Naarden, Netherlands. See contact routes.

About BioGeneration Ventures

BioGeneration Ventures (BGV) is an early-stage venture capital firm based in Naarden, Netherlands, founded in 2006 by Edward van Wezel as the seed-stage arm of the Forbion-BGV platform. The firm invests primarily in European biotechnology, medtech, and diagnostics companies that translate academic research into novel therapeutics addressing unmet medical needs. BGV typically acts as a lead investor or company creator, focusing on seed to early-growth stages with a geographic emphasis on Europe, particularly the Benelux region and Germany. Its typical check size ranges from €100,000 to €1 million, with a sweet spot around €500,000, though historical averages reach approximately $8.2 million. Notable portfolio companies include Acerta Pharma (acquired by AstraZeneca for up to $7 billion), Dezima Pharma (sold to Amgen for $1.55 billion), Synaffix, and argenx. BGV’s distinctive point of view centers on rigorous selection of projects with strong proof-of-concept potential, combining deep scientific expertise with commercial insight to guide companies through clinical development to successful exits.

BioGeneration Ventures at a glance

Location
Netherlands
Investor type
Venture Capital

Frequently asked about BioGeneration Ventures

What does BioGeneration Ventures invest in?
We have not verified a stated sector or stage focus for BioGeneration Ventures (Netherlands). The profile lists the organization, location and investors we track alongside them.
How do I contact BioGeneration Ventures?
BioGeneration Ventures's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.
Where is BioGeneration Ventures headquartered?
BioGeneration Ventures is based in Netherlands.

Every field above is read from the StartupFundraising firm directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Netherlands when building a target list.

Investors similar to BioGeneration Ventures (20)

Browse related investor lists (1)

Compare BioGeneration Ventures (8)

Investors like BioGeneration Ventures · Full investor directory · Investor access · Company funding database

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades